comparemela.com

Latest Breaking News On - சோதனை சிகிச்சை - Page 2 : comparemela.com

International Biotechnology Trust : Factsheet

Dana-Farber Cancer Institute Establishes David Liposarcoma Research Initiative

Date Time Dana-Farber Cancer Institute Establishes David Liposarcoma Research Initiative Dana-Farber Cancer Institute announced that The Rossy Foundation has committed $10 million to establish the David Liposarcoma Research Initiative. The five-year initiative will spearhead groundbreaking research into liposarcoma at Dana-Farber and external collaborating partner institutions, with the aim of transforming the treatment of this rare, underfunded, and understudied disease in order to improve care of patients through research. This commitment from The Rossy Foundation will focus on collaborative research among various departments at Dana-Farber-including liposarcoma biology, biochemistry, immunology, metabolism, genomics, and epigenetics. By conducting research to improve fundamental understanding of the molecular mechanisms of this disease, the initiative may lead to new approaches to overcome treatment resistance, as well as new strategies for clinical research to improve the outc

Cancer Center Maintains Highest Level of Distinction

UMB News Support UMB s Increasing Efforts to Deal with the COVID-19 Pandemic During this important period, please consider supporting UMB s critical vaccine research and development, advancing its work in human virology, and donating to critical emergency funds especially designed for specific students in need.  We truly appreciate your gifts in this time of great need.  July 23, 2021 The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has earned renewal of its National Cancer Institute (NCI) designation as a Comprehensive Cancer Center for another five years. The prestigious distinction recognizes the cancer center’s high caliber of scientific leadership and robust programs in basic, clinical, and population science research, placing it in the top echelon of cancer centers nationwide.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.